SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 100 of 100
Features
Bristol-Myers profits beat estimates as it readies new immuno-harnessing cancer drug
By
Laura Lorenzetti
July 24, 2014
Finance
Allergan says it will cut 13% of its global workforce
By
Laura Lorenzetti
July 21, 2014
Finance
AbbVie, Shire agree on merger terms in latest “inversion” deal
By
Geoffrey Smith
July 18, 2014
Google, Novartis ready to make reading glasses obsolete
By
Laura Lorenzetti
July 17, 2014
International
Europe 2Q earnings highlights: SAP lifted by Cloud billings
By
Geoffrey Smith
July 17, 2014
Finance
Vertex gets tangled in Medicaid lawsuit
By
Laura Lorenzetti
July 17, 2014
Features
J&J’s pharmaceutical prowess drives surging sales
By
Laura Lorenzetti
July 15, 2014
Retail
CVS Caremark takes aim at Hispanic, specialty pharmacy market with Navarro deal
By
Phil Wahba
July 14, 2014
International
AbbVie starts talks with Shire after raising bid to $53.6 billion
By
Geoffrey Smith
July 14, 2014
Finance
Allergan’s CEO ready to make deals to fend off Valeant offer
By
Laura Lorenzetti
July 10, 2014
International
AbbVie raises bid for U.K.’s Shire Pharmaceuticals
By
Geoffrey Smith
July 8, 2014
Finance
Actavis gave execs as much as $186 million in merger success awards
By
Laura Lorenzetti
July 7, 2014
International
Roche buys breast cancer specialist Seragon for $1.7 billion
By
Geoffrey Smith
July 2, 2014
Finance
Sex tape was sent to Glaxo before start of China corruption probe
By
Geoffrey Smith
June 30, 2014
Retail
Walgreen’s results lifted by strong prescription sales
By
John Kell
June 24, 2014
Most Popular
AI
Meta's 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is 'vibe coding' right now
By
Eva Roytburg
Commentary
Behind closed doors, our top CEOs say Trump is bad for business and it's time to Make America into America Again
By
Jeffrey Sonnenfeld
and
Stephen Henriques
Politics
First Tucker Carlson, now Ted Cruz: Conservatives are talking about an ‘unbelievably dangerous’ precedent being set by...
By
Nino Paoli